Epitalon

A synthetic bioregulator peptide (tetrapeptide) marketed around telomeres and sleep — the Russian-research lineage entry in the six.

⚠ Safety first — read this before anything else on this page

Approval status: Epitalon is not FDA-approved for any use. As of November 2026 it sits inside the draft federal enforcement-discretion policy — discretion is not approval.

What has actually happened to people:

No human harm record exists in the Western literature — because human safety data are near zero. The documented problem with gray-market epitalon is the product itself: epitalon was one of the ten falsified peptide drugs in a Belgian public-health lab study (Janvier et al., Talanta, 2018), a set in which purity ran as low as 5–75% for some compounds and about 30% of samples carried incorrect amino-acid sequences.
A clinician creator reports a fade pattern in practice — strong sleep effects for a few days, then the effect wears off (Dr. Froese, describing receptor desensitization; clinician-attributed, not a study).

What nobody knows: Human safety data are near zero, and the Russian bioregulator literature behind epitalon is not independently replicated. The telomerase story also cuts both ways in theory: the mechanism marketed as anti-aging is one oncologists associate with immortalized cells — a theoretical tension, clearly labeled, not a finding.

Get medical care now if:

Swelling of the lips or tongue, or trouble breathing, after any injection — call emergency services.
An injection site that worsens over days, or a lump appearing one to several weeks later — the delayed infection pattern; it needs a clinician.
Sleep or mood changes that persist after stopping — tell a clinician what you were taking.

Who should stay away: Anyone with a cancer history or an undiagnosed growth — the telomerase question above is unresolved, and this is not the compound to experiment with around it. Also: minors and anyone pregnant.

The product problem: Epitalon was itself in the falsified-product set of the 2018 Belgian lab study (Janvier et al., Talanta) — two-thirds of the products tested were below 95% purity, with inorganic arsenic up to ten times the limit for injectable drugs found in the set.

Talk to a doctor who knows you are taking it. See our doctors directory. If you were harmed, report it to FDA MedWatch — your report is how the record gets built.

We don't publish doses, protocols, or sources — for any compound, ever. Our Legal Mandate.

What it is

A synthetic bioregulator peptide (tetrapeptide) marketed around telomeres and sleep — the Russian-research lineage entry in the six.

What creators claim

Creators describe epitalon as a telomere-lengthening and sleep-normalizing peptide from the Khavinson bioregulator tradition. Dr. Froese uses it as her teaching example of receptor desensitization: strong sleep effects for about three days, then 3 a.m. wakefulness returns — her illustration that receptors adapt (see Receptor Saturation).

What the evidence shows

Near-zero human safety or efficacy data in the Western literature; the bioregulator evidence tradition is largely Russian-language and institute-published. That thinness is the fact to know.

Forms it is discussed in

Injectable and oral forms are discussed in bioregulator circles.

Dangers on record

The danger is the unknown itself: almost no human data, long-term effects unstudied, and desensitization reported anecdotally by clinicians. See Dangers.

Legal status (as of November 7, 2026)

Not FDA-approved. PCAC voted 7–4 for the Bulks List (July 2026); not on the list. One of the six in the October 30 enforcement-discretion policy (acetate, single-ingredient, conditions). Not to be confused with DSIP/emideltide — the one nominee the PCAC rejected.